JUNO THERAPEUTICS INC's ticker is JUNO and the CUSIP is 48205A109. A total of 214 filers reported holding JUNO THERAPEUTICS INC in Q3 2017. The put-call ratio across all filers is 0.99 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $911,000 | +323.7% | 20,305 | +78.1% | 0.02% | +283.3% |
| Q4 2016 | $215,000 | -5.7% | 11,400 | +120.2% | 0.01% | 0.0% |
| Q4 2015 | $228,000 | -31.9% | 5,176 | -17.6% | 0.01% | -40.0% |
| Q2 2015 | $335,000 | +33.5% | 6,282 | +52.0% | 0.01% | +25.0% |
| Q1 2015 | $251,000 | -92.1% | 4,133 | -93.2% | 0.01% | -92.7% |
| Q4 2014 | $3,166,000 | – | 60,631 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|